U.S. market Closed. Opens in 1 day 5 hours 3 minutes

RETA | Reata Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue2.22M11.49M9.02M26.52M53.59M48.06M49.86M50.32M51.95M51.20M
Cost of RevenueN/AN/AN/A124.40MN/AN/AN/AN/AN/AN/A
Gross Profit2.22M11.49M9.02M-97.88M53.59M48.06M49.86M50.32M51.95M51.20M
Operating Expenses280.25M256.20M235.34M187.34M130.47M94.97M56.74M50.65M48.33M61.58M
Selling, General & Admin109.28M99.00M75.13M58.30M32.75M23.26M16.60M13.69M11.51M13.40M
Research & Development169.84M155.99M159.08M128.11M97.29M71.27M39.45M35.14M34.30M45.25M
Other Operating Expenses1.13M1.20M1.14M932.00K431.00K-3.00KN/AN/AN/AN/A
Operating Income-270.15M-244.71M-226.32M-285.22M-76.88M-46.91M-7.10M-366.00K3.58M-10.42M
Other Expenses / Income-33.89M-53.13M-43.91M-4.94M-3.64M-1.19M428.00K32.00K86.00K36.00K
Before Tax Income-311.93M-297.84M-270.24M-290.16M-80.52M-47.67M-6.67M-302.00K3.67M-10.35M
Income Tax Expenses-25.00K-450.00K-22.49M8.00K26.00K3.00K-441.00K1.15M2.98M24.76M
Net Income-311.90M-297.39M-247.75M-290.17M-80.55M-47.67M-6.23M-1.45M689.00K-35.10M
Interest Expenses41.77M53.25M36.78M11.20M6.18M1.45MN/AN/AN/AN/A
Basic Shares Outstanding36.32M36.32M33.71M30.41M27.70M23.93M19.82M5.50M5.50M5.50M
Diluted Shares Outstanding36.32M36.32M33.71M30.41M27.70M23.93M19.82M5.50M20.00M20.00M
EBITDA-269.02M-243.50M-232.32M-278.03M-73.91M-46.48M-6.41M1.45M6.09M-7.49M
EBITDA Margin-12,140.12%-2,119.28%-2,575.94%-1,048.51%-137.93%-96.71%-12.87%2.89%11.73%-14.63%
EBIT-270.15M-244.59M-233.46M-278.96M-74.34M-46.21M-6.67M-302.00K3.67M-10.35M
EBIT Margin-12,191.11%-2,128.68%-2,588.54%-1,052.02%-138.73%-96.16%-13.37%-0.60%7.06%-20.21%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙